Form 144 - Report of proposed sale of securities:
SEC Accession No. 0000902664-25-004073
Filing Date
2025-09-12
Accepted
2025-09-12 16:05:13
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 3467
  Complete submission text file 0000902664-25-004073.txt   5358
Mailing Address TEVA PHARMACEUTICAL INDUSTRIES LIMITED 124 DVORA HANEVI'A ST. TEL AVIV Israel
Business Address TEVA PHARMACEUTICAL INDUSTRIES LIMITED 124 DVORA HANEVI'A ST. TEL AVIV Israel 972 (3) 914-8213
TEVA PHARMACEUTICAL INDUSTRIES LTD (Subject) CIK: 0000818686 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-16174 | Film No.: 251311498
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 90 PARK AVENUE, 40TH FLOOR NEW YORK NY 10016
Business Address 90 PARK AVENUE, 40TH FLOOR NEW YORK NY 10016 212-918-0820
BRIDGER MANAGEMENT, LLC (Reporting) CIK: 0001166309 (see all company filings)

EIN.: 582553507 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144